期刊文献+

B 型尿钠肽与2型糖尿病发生风险相关

B-type natriuretic peptide and risk of type 2 diabetes mellitus
原文传递
导出
摘要 目的:研究氨基末端前B型尿钠肽(NT-proBNP)与2型糖尿病发病的独立相关性。方法对经糖耐量试验(OGTT)确定为糖调节受损人群随访2年(n=126),在基线时抽取受试者静脉血测定血浆中NT-proBNP。结果基线时NT-proBNP与体重指数、腰围、空腹血糖、空腹胰岛素、低密度脂蛋白胆固醇( LDL-C)负相关。在随访2年时,有51例新发糖尿病。经过多变量分析调整后,基线NT-proBNP仍与糖尿病风险负相关,调整的相对危险度在第1~4四分位数组分别为1.0(参照)、0.83(95%CI 0.74~0.96)、0.78(95%CI 0.68~0.90)、0.74(95%CI 0.64~0.87;P<0.01)。结论在糖调节受损人群中,低水平的NT-proBNP与糖尿病风险升高相关。 Objective To explore the association of NH2-terminal pro-B-type natriuretic peptide ( NT-proBNP) with the risk of type 2 diabetes.Methods One hundred and twenty-six impaired glucose regulation( IGR) participants from Diabetic Identification Center of Tianjin Metabolic Diseases Hospital were included.NT-proBNP was measured in plasma samples collected from participants at baseline condition.Results At baseline, NT-proBNP was inversely associated with body mass index, waist circumference, fasting glucose, insulin and low-density lipoprotein-cholesterol( LDL-C) levels.During a follow-up of 2 years, 51 participants reported a new diagnosis of diabetes from OGTT.Baseline quartiles of NT-proBNP were inversely associated with diabetes risk, even after multivariable adjustment.Theadjustedrelativerisksfordiabeteswere1.0(reference),0.83(95%CI0.74-0.96),0.78(95%CI 0.68-0.90), 0.74 (95%CI 0.64-0.87) for the 1st, 2nd, 3rd, and 4th quartiles of baseline NT-proBNP, respectively ( P〈0.01 ) .Conclus ion In IGRpopulation , lowlevels of NT-proBNP were associated with a significantly increased risk of type 2 diabetes.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2016年第2期103-106,共4页 Chinese Journal of Endocrinology and Metabolism
关键词 B型尿钠肽 糖尿病 2型 糖调节受损 B-type natriuretic peptide Diabetes mellitus, type 2 Impaired glucose regulation
  • 相关文献

参考文献15

  • 1Levin ER, Gardner DG, Samson WK. Natriuretic peptides [ J ]. N Engl J Med, 1998,339(5) :321-328.
  • 2Heinisch BB, Vila G, Resl M, et al. B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose : a randomised placebo- controlled cross-over studyin heahhy men[J]. Diabetologia, 2012,55 (5) :1400-1405.
  • 3Miyashita K, Itoh H, Tsujimoto H, et al. Natriuretic peptides/eGMP/ eGMP dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity [ J ]. Diabetes, 2009,58 ( 12 ) : 2880- 2892.
  • 4Wang TJ. The natriuretic peptides and fat metabolism [ J ]. N Engl J Med, 2012,367 (5) :377-378.
  • 5Sarzani R, Desst-Fulgheri P, Paei VM, et al. Expression of natriuretie peptide receptors in human adipose and other tissues [ J ]. J Endocrinol Invest, 1996,19(9) :581-585.
  • 6Bordieehia M, Liu D, Amri EZ, et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenie program in mouse and human adipoeytes[ J]. J Clin Invest, 2012,122 ( 3 ) : 1022-1036.
  • 7Das SR, Drazner MH, Dries DL, et al. Impact of body mass and body composition on circulating levels of natriuretic peptides : results from theDallas Heart Study[J]. Circulation, 2005,112(14) :2163-2168.
  • 8Khan AM, Cheng S, Magnusson M, et al. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies [ J ]. J Clin Endocrinol Metab, 2011,96 ( 10 ) : 3242-3249.
  • 9Wang TJ, Larson MG, Keyes MJ, et al. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals[ J]. Circulation, 2007,115 ( 11 ) : 1345-1353.
  • 10Magnusson M, Jujic A, Hedblad B, et al. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study[ J]. J Clin Endocrinol Metab, 2012,97 (2) :638-645.

二级参考文献50

共引文献1142

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部